IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,142 | -40.9% | 45,646 | -2.7% | 0.00% | – |
| Q2 2023 | $130,446 | +79.3% | 46,923 | +17.4% | 0.00% | – |
| Q1 2023 | $72,758 | -63.9% | 39,977 | +0.6% | 0.00% | – |
| Q4 2022 | $201,533 | +2.5% | 39,750 | +0.5% | 0.00% | – |
| Q3 2022 | $196,593 | +30.7% | 39,556 | -2.2% | 0.00% | – |
| Q2 2022 | $150,414 | -24.8% | 40,434 | +13.5% | 0.00% | – |
| Q1 2022 | $199,929 | -21.0% | 35,638 | -14.4% | 0.00% | – |
| Q4 2021 | $253,000 | -35.8% | 41,623 | +2.9% | 0.00% | – |
| Q3 2021 | $394,000 | -35.2% | 40,468 | -4.9% | 0.00% | – |
| Q2 2021 | $608,000 | +33.6% | 42,551 | +121.9% | 0.00% | – |
| Q1 2021 | $455,000 | – | 19,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $4,180,000 | 0.56% |
| HARBOURVEST PARTNERS LLC | 335,709 | $2,041,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $586,000 | 0.20% |
| SHEETS SMITH WEALTH MANAGEMENT | 152,276 | $926,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 129,260 | $786,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 140,551 | $855,000 | 0.09% |
| Virtus ETF Advisers LLC | 28,969 | $176,000 | 0.07% |
| XTX Topco Ltd | 19,159 | $116,000 | 0.07% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 49,464 | $301,000 | 0.04% |
| Vident Investment Advisory, LLC | 168,476 | $1,024,000 | 0.03% |